FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977584244> ?p ?o ?g. }

• W1977584244 endingPage "1301" @default.
• W1977584244 startingPage "1290" @default.
• W1977584244 abstract "Selection of a suitable formulation that provides adequate product stability is an important aspect of the development of biopharmaceutical products. Stability of proteins includes not only resistance to chemical modifications but also conformational and colloidal stabilities. While chemical degradation of antibodies is relatively easy to detect and control, propensity for conformational changes and/or aggregation during manufacturing or long-term storage is difficult to predict. In many cases, the formulation factors that increase one type of stability may significantly decrease another type under the same or different conditions. Often compromise is necessary to minimize the adverse effects of an antibody formulation by careful optimization of multiple factors responsible for overall stability. In this study, high-throughput stress and characterization techniques were applied to 96 formulations of anti-streptavidin antibodies (an IgG1 and an IgG2) to choose optimal formulations. Stress and analytical methods applied in this study were 96-well plate based using an automated liquid handling system to prepare the different formulations and sample plates. Aggregation and clipping propensity were evaluated by temperature and mechanical stresses. Multivariate regression analysis of high-throughput data was performed to find statistically significant formulation factors that alter measured parameters such as monomer percentage or unfolding temperature. The results of the regression models were used to maximize the stabilities of antibodies under different formulations and to find the optimal formulation space for each molecule. Comparison of the IgG1 and IgG2 data indicated an overall greater stability of the IgG1 molecule under the conditions studied. The described method can easily be applied to both initial preformulation screening and late-stage formulation development of biopharmaceutical products." @default.
• W1977584244 created "2016-06-24" @default.
• W1977584244 creator A5020393653 @default.
• W1977584244 creator A5053107351 @default.
• W1977584244 creator A5062731249 @default.
• W1977584244 creator A5084769779 @default.
• W1977584244 creator A5089005621 @default.
• W1977584244 date "2014-10-01" @default.
• W1977584244 modified "2023-10-14" @default.
• W1977584244 title "High-Throughput Screening and Stability Optimization of Anti-Streptavidin IgG1 and IgG2 Formulations" @default.
• W1977584244 cites W1967693680 @default.
• W1977584244 cites W1968130865 @default.
• W1977584244 cites W1973185731 @default.
• W1977584244 cites W1976972758 @default.
• W1977584244 cites W1979780600 @default.
• W1977584244 cites W1983554592 @default.
• W1977584244 cites W1994016286 @default.
• W1977584244 cites W1998576094 @default.
• W1977584244 cites W2011881868 @default.
• W1977584244 cites W2030516118 @default.
• W1977584244 cites W2035538026 @default.
• W1977584244 cites W2044344419 @default.
• W1977584244 cites W2068651607 @default.
• W1977584244 cites W2073259523 @default.
• W1977584244 cites W2076100371 @default.
• W1977584244 cites W2076571844 @default.
• W1977584244 cites W2085735648 @default.
• W1977584244 cites W2091513759 @default.
• W1977584244 cites W2094731078 @default.
• W1977584244 cites W2094731907 @default.
• W1977584244 cites W2096324068 @default.
• W1977584244 cites W2111559671 @default.
• W1977584244 cites W2125016536 @default.
• W1977584244 cites W2153245626 @default.
• W1977584244 cites W2159351791 @default.
• W1977584244 cites W2159840467 @default.
• W1977584244 cites W2160374669 @default.
• W1977584244 cites W3004335124 @default.
• W1977584244 cites W4379509319 @default.
• W1977584244 doi "https://doi.org/10.1177/1087057114542431" @default.
• W1977584244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25023322" @default.
• W1977584244 hasPublicationYear "2014" @default.
• W1977584244 type Work @default.
• W1977584244 sameAs 1977584244 @default.
• W1977584244 citedByCount "20" @default.
• W1977584244 countsByYear W19775842442015 @default.
• W1977584244 countsByYear W19775842442016 @default.
• W1977584244 countsByYear W19775842442017 @default.
• W1977584244 countsByYear W19775842442020 @default.
• W1977584244 countsByYear W19775842442021 @default.
• W1977584244 countsByYear W19775842442022 @default.
• W1977584244 countsByYear W19775842442023 @default.
• W1977584244 crossrefType "journal-article" @default.
• W1977584244 hasAuthorship W1977584244A5020393653 @default.
• W1977584244 hasAuthorship W1977584244A5053107351 @default.
• W1977584244 hasAuthorship W1977584244A5062731249 @default.
• W1977584244 hasAuthorship W1977584244A5084769779 @default.
• W1977584244 hasAuthorship W1977584244A5089005621 @default.
• W1977584244 hasBestOaLocation W19775842441 @default.
• W1977584244 hasConcept C112972136 @default.
• W1977584244 hasConcept C119857082 @default.
• W1977584244 hasConcept C150903083 @default.
• W1977584244 hasConcept C157764524 @default.
• W1977584244 hasConcept C185592680 @default.
• W1977584244 hasConcept C186060115 @default.
• W1977584244 hasConcept C192562407 @default.
• W1977584244 hasConcept C2776190903 @default.
• W1977584244 hasConcept C2778204606 @default.
• W1977584244 hasConcept C2781047461 @default.
• W1977584244 hasConcept C41008148 @default.
• W1977584244 hasConcept C43617362 @default.
• W1977584244 hasConcept C51323132 @default.
• W1977584244 hasConcept C55493867 @default.
• W1977584244 hasConcept C555944384 @default.
• W1977584244 hasConcept C76155785 @default.
• W1977584244 hasConcept C86803240 @default.
• W1977584244 hasConceptScore W1977584244C112972136 @default.
• W1977584244 hasConceptScore W1977584244C119857082 @default.
• W1977584244 hasConceptScore W1977584244C150903083 @default.
• W1977584244 hasConceptScore W1977584244C157764524 @default.
• W1977584244 hasConceptScore W1977584244C185592680 @default.
• W1977584244 hasConceptScore W1977584244C186060115 @default.
• W1977584244 hasConceptScore W1977584244C192562407 @default.
• W1977584244 hasConceptScore W1977584244C2776190903 @default.
• W1977584244 hasConceptScore W1977584244C2778204606 @default.
• W1977584244 hasConceptScore W1977584244C2781047461 @default.
• W1977584244 hasConceptScore W1977584244C41008148 @default.
• W1977584244 hasConceptScore W1977584244C43617362 @default.
• W1977584244 hasConceptScore W1977584244C51323132 @default.
• W1977584244 hasConceptScore W1977584244C55493867 @default.
• W1977584244 hasConceptScore W1977584244C555944384 @default.
• W1977584244 hasConceptScore W1977584244C76155785 @default.
• W1977584244 hasConceptScore W1977584244C86803240 @default.
• W1977584244 hasIssue "9" @default.
• W1977584244 hasLocation W19775842441 @default.
• W1977584244 hasLocation W19775842442 @default.
• W1977584244 hasOpenAccess W1977584244 @default.
• W1977584244 hasPrimaryLocation W19775842441 @default.

• next